Albemarle Corporation

Albemarle Corporation's Board of Directors approved Ragnar Udd as the successor to J. Kent Masters Jr. as President and Chief Executive Officer, effective February 1, 2027, or earlier by mutual agreement. This planned CEO transition reflects deliberate succession planning at the lithium and specialty chemicals company. The filing also includes a Reg FD press release (Item 7.01) announcing the leadership change. Udd's appointment signals a structured handover of the top executive role.

Max Hood, newly appointed Chief Accounting Officer of Albemarle Corp, filed a Form 3 initial statement of beneficial ownership on August 25, 2026, with a triggering event date of August 24, 2026. No securities of Albemarle are currently beneficially owned by Hood. This is a routine administrative filing required within 10 days of becoming subject to Section 16 reporting obligations as a new corporate officer.

Eduardo De Salles Bartolomeo filed Form 3 (Initial Statement of Beneficial Ownership) following his appointment as a director of Albemarle Corporation, effective July 21, 2026. The form was signed by attorney-in-fact Corey E. Tanner on July 23, 2026. Tables I and II contain no entries — Bartolomeo holds no Albemarle securities at the time of the initial filing. As required by Section 16(a), this baseline filing must be made within 10 days of becoming an insider; future Form 4 filings will track any equity grants received under ALB's standard non-employee director compensation program.

Albemarle Corporation appointed Eduardo De Salles Bartolomeo as an independent board member, effective July 21, 2026, under Item 5.02. He was assigned to the Audit and Finance Committee and the Safety, Sustainability, Operations & Capital Committee. Compensation follows the standard non-employee director program: a $120,000 annual cash retainer (quarterly, pro-rated for partial year) and approximately $170,000 in annual restricted stock (rounded up to the nearest 25 shares, pro-rated). No undisclosed arrangements or related-party transactions exist in connection with his selection. Adding an independent director with relevant industrial background strengthens governance at a time when ALB is navigating a lithium market downturn and restructuring its cost base.

ALB (ALB) filed an 8-K under Item 5.02 disclosing a change in its executive leadership or board composition. The filing reports both a departure and an appointment in Chief Financial Officer. Individuals named in the filing include The Securities, Employer Identification. Leadership changes at the C-suite and board level are material events requiring 8-K disclosure within four business days, as they can affect company strategy, investor confidence, and operational continuity.

ALB disclosed a personnel change (8-K Item 5.02, dated 2026-05-08). An executive departure and a new appointment are both reported. Personnel changes are generally administrative; materiality depends on seniority and circumstances.